KLSE (MYR): DPHARMA (7148)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.15
Today's Change
-0.01 (0.86%)
Day's Change
1.14 - 1.16
Trading Volume
258,800
Market Cap
1,106 Million
NOSH
962 Million
Latest Quarter
31-Dec-2023 [#4]
Announcement Date
22-Feb-2024
Next Quarter
31-Mar-2024
Est. Ann. Date
22-May-2024
Est. Ann. Due Date
30-May-2024
QoQ | YoY
-5.22% | -50.46%
Revenue | NP to SH
704,727.000 | 52,646.000
RPS | P/RPS
73.26 Cent | 1.57
EPS | P/E | EY
5.47 Cent | 21.01 | 4.76%
DPS | DY | Payout %
2.30 Cent | 2.00% | 41.99%
NAPS | P/NAPS
0.71 | 1.62
QoQ | YoY
-14.12% | -24.91%
NP Margin | ROE
7.47% | 7.71%
F.Y. | Ann. Date
31-Dec-2023 | 22-Feb-2024
Latest Audited Result
31-Dec-2022
Announcement Date
27-Apr-2023
Next Audited Result
31-Dec-2023
Est. Ann. Date
27-Apr-2024
Est. Ann. Due Date
28-Jun-2024
Revenue | NP to SH
704,727.000 | 52,645.000
RPS | P/RPS
73.26 Cent | 1.57
EPS | P/E | EY
5.49 Cent | 21.01 | 4.76%
DPS | DY | Payout %
2.30 Cent | 2.00% | 42.03%
NAPS | P/NAPS
0.71 | 1.62
YoY
-24.91%
NP Margin | ROE
7.47% | 7.71%
F.Y. | Ann. Date
31-Dec-2023 | 22-Feb-2024
Revenue | NP to SH
704,727.000 | 52,645.000
RPS | P/RPS
73.26 Cent | 1.57
EPS | P/E | EY
5.49 Cent | 21.01 | 4.76%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-10.55% | -24.91%
NP Margin | ROE
7.47% | 7.71%
F.Y. | Ann. Date
31-Dec-2023 | 22-Feb-2024
Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Tmr up, those that trapped at high better sell after gap up, other people who bought at bottom want to top up.
2023-02-23 21:05
Pharma's problems are, 1) RM600mil worth of Covid vaccines expiring soon, 2) their short term debt stands at almost RM1bil.
Dpharma doesn't have both those problems.
2023-02-28 17:23
QR is out :
net profit rose 11.54% to RM22.63 million for 1QFY2023, from RM20.29 million a year earlier, on the back of higher revenue amid increased sales to the prescription pharmaceutical market. Earnings per share improved to 2.38 sen, from 2.19 sen in 1QFY2022, Quarterly revenue grew 7.82% to RM200.48 million from RM185.94 million.
2023-05-23 05:53
Got 21mil profit but share price not moving. Volume so low.
No sesy sesy stories share price how to fly? Last time got vaccine story. Now?
2023-05-23 13:49
[转贴] [Video:浅谈DUOPHARMA BIOTECH BERHAD, DPHARMA, 7148] - James的股票投资James Share Investing
https://klse.i3investor.com/web/blog/detail/general/2023-08-12-story-h-242875199
2023-08-12 21:08
Quarter results already reflected in the price before the release of the Q2 report
2023-08-25 11:37
Managed and operated by white haired people sitting in wheel chairs and using walking sticks. Most have prostate problems, waking few times at night to urinate. Some are waiting for stairways to Heavens........HOW COULD COMPANY BE AGGRESSIVE???
2023-10-08 13:10
3Q23 profits down 45% YoY....current BOD is a team of silver haired centennials in wheelchairs. Raising 2 Billion bonds for retirement benefits?
BOD too aggressive is bad, weak BOD is also bad.......take your pick.
2023-11-10 12:07
Pharma is dying, yet this ctnr with Management in wheelchairs cannot take advantage.
2023-12-02 09:04
This is just reaction to Covid case spike, after that fall back down. Nothing new and exciting on the horizon for pharma in the coming months especially when Pharmaniaga still in the dump and government cutting back on spending.
2023-12-15 16:03
Hope this collaboration can bring good revenue to the company for Fy2024 and so on
https://theedgemalaysia.com/node/692365
2024-01-15 17:14
Duopharma Biotech Bhd is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.
https://www.thestar.com.my/business/business-news/2024/01/26/duopharma-earnings-set-to-improve-this-year
2 months ago
This is my trading call dated 15 Dec 2020. Most of the time chart will tell the true story:
https://www.tradingview.com/chart/DPHARMA/5tKe08jN-Trend-Analysis/
For investment or trading ideas, please feel free to visit my chart gallery:
https://www.tradingview.com/u/Yang358/#published-charts
2 months ago
I love astronomy so most of my calculation/logics actually somehow related to astrophysics and planetary orbit. Something to do with price resistance, time resistance and speed resistance.
2 months ago
pang72
DPHARMA up too..
But, I don't hv..
Because glc link.
.
2022-12-21 11:57